New Sterically Stabilized Vesicles Based on Nonionic Surfactant, Cholesterol, and Poly(Ethylene Glycol)-Cholesterol Conjugates  by Beugin, Sophie et al.
New Sterically Stabilized Vesicles Based on Nonionic Surfactant,
Cholesterol, and Poly(Ethylene Glycol)-Cholesterol Conjugates
Sophie Beugin,* Katarina Edwards,# Go¨ran Karlsson,# Michel Ollivon,* and Sylviane Lesieur*
*Equipe Physico-Chimie des Syste`mes Polyphase´s, URA CNRS 1218, Universite´ Paris-Sud, F-92296 Chaˆtenay-Malabry, France, and
#Department of Physical Chemistry, Uppsala University, S-75121 Uppsala, Sweden
ABSTRACT Monomethoxypoly(ethylene glycol) cholesteryl carbonates (M-PEG-Chol) with polymer chain molecular weights
of 1000 (M-PEG1000-Chol) and 2000 (M-PEG2000-Chol) have been newly synthesized and characterized. Their aggregation
behavior in mixture with diglycerol hexadecyl ether (C16G2) and cholesterol has been examined by cryotransmission electron
microscopy, high-performance gel exclusion chromatography, and quasielastic light scattering. Nonaggregated, stable,
unilamellar vesicles were obtained at low polymer levels with optimal shape and size homogeneity at cholesteryl conjugate/
lipids ratios of 10 mol% M-PEG1000-Chol or 5 mol% M-PEG2000-Chol, corresponding to the theoretically predicted brush
conformational state of the PEG chains. At 20 mol% M-PEG1000-Chol or 10 mol% M-PEG2000-Chol, the saturation
threshold of the C16G2/cholesterol membrane in polymer is exceeded, and open disk-shaped aggregates are seen in
coexistence with closed vesicles. Higher levels up to 30 mol% lead to the complete solubilization of the vesicles into disk-like
structures of decreasing size with increasing PEG content. This study underlines the bivalent role of M-PEG-Chol derivatives:
while behaving as solubilizing surfactants, they provide an efficient steric barrier, preventing the vesicles from aggregation
and fusion over a period of at least 2 weeks.
INTRODUCTION
For the past 20 years, synthetic polyglycerol n-alkyl ethers
or esters capable of combining with high amounts of cho-
lesterol have proved to form biocompatible vesicular struc-
tures that are chemically and physically stable, character-
ized by a reduced membrane permeability to lipid- or water-
soluble solutes (Vanlerberghe et al., 1978; Handjani-Vila et
al., 1979, 1982; Uchegbu and Florence, 1995). These non-
ionic surfactant vesicles (NSVs), originally named “nio-
somes” (Vanlerberghe et al., 1978), have been worthily
promoted to potential alternatives to liposomal delivery
systems (Florence and Baillie, 1989). Most studies have
indeed shown that NSVs prolong the circulation of en-
trapped drugs (Uchegbu and Florence, 1995; Azmin et al.,
1985, 1986; Baillie et al., 1986; Hunter et al., 1988; Carter
et al., 1988; Rogerson et al., 1987, 1988; Kerr et al., 1988;
Raja Naresh and Udupa, 1996) or diagnostic markers (Er-
dogan et al., 1996). On the other hand, very little informa-
tion focusing on the metabolism of NSVs themselves upon
intravenous administration has been reported. It would
seem, however, that to date, NSVs do not exhibit noticeably
long circulation times in the bloodstream and thus behave in
vivo like conventional phospholipidic vesicles (Azmin et
al., 1985; Woodle and Lasic, 1992). In this respect, it has
been widely demonstrated that the incorporation into the
vesicle bilayer of glycolipids like monosialoganglioside
GM1 (Allen, 1992, 1994a; Allen and Papahadjopoulos,
1993; Oku and Namba, 1994), or of lipids derivatized with
hydrophilic polymers, like polysaccharides (Akiyoshi and
Sunamoto, 1992; Sato and Sunamoto, 1993) or, preferen-
tially, poly(ethylene glycol) (PEG) (Woodle and Lasic,
1992; Allen, 1992, 1994a; Allen and Papahadjopoulos,
1993; Oku and Namba, 1994; Lasic and Needham, 1995;
Woodle, 1993, 1995; Trubetskoy and Torchilin, 1995;
Torchilin and Trubetskoy, 1995), significantly delays rec-
ognition and uptake by the cells of the reticuloendothelial
system. The particular efficiency of surface-attached PEG
chains has been explained by the combination of their water
solubility and flexibility, which sterically stabilizes the ves-
icles, mainly preventing them from self-aggregation and/or
fusion processes, as well as from opsonin adsorption (Need-
ham et al., 1992; Lasic, 1994; Torchilin, 1996). Grafting
PEG onto lipids through covalent bonding presents certain
advantages. According to the chemical reactivity of the
terminal hydroxyl groups, numerous compounds can be
envisaged with characteristics befitting the host vesicle
membrane. For instance, the lipid to be modified can be
chosen from among the constituents of the initial lipid
bilayer, and the chain length of the polymer moieties can be
adjusted with regard to the wide range of available PEG
molecular weights. The nature of the linkage between the
PEG chain and the hydrophobic anchor can also be varied
(Woodle and Lasic, 1992). Finally, the possible heterobi-
functionalization of PEG allows subsequent attachment of
biologically active or even cell-targeting molecules to the
far end of the grafted polymer chain (Allen, 1994b, 1995;
Blume et al., 1993).
The purpose of the present work is to introduce into the
NSV membrane PEGylated additives exerting steric stabi-
lization while preserving the original properties of the bi-
layer. Within the last 6 years, we have been especially
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interested in the physical characteristics and impermeability
properties of NSVs composed of diglycerol hexadecyl ether
(C16G2), cholesterol, and a small proportion of dicetylphos-
phate (DCP). These vesicles have revealed remarkable sta-
bility with time and strong resistance to solubilizing surfac-
tants like octyl glucoside (Lesieur et al., 1990; Seras et al.,
1992, 1993, 1994, 1996; Seras-Cansell et al., 1996) or
Triton X-100 (Vanlerberghe and Moranc¸ais, 1996). Inter-
estingly, these properties are connected to the condensing
effect of cholesterol, present in nearly equimolar propor-
tions with C16G2 (Vanlerberghe et al., 1978). Indeed, cho-
lesterol is well known to confer cohesion on lipid bilayers
by inducing tighter molecular packing and restricted mo-
tions of the hydrocarbon chains (Sankaram and Thompson,
1990; McMullen and McElhaney, 1996). The incorporation
of DCP undoubtedly contributes to the stabilization of NSV
dispersions (Seras et al., 1992; Florence, 1993). However, if
the presence of a net electrical charge at the surface of the
vesicles impedes their aggregation by creating repulsive
forces, it inversely enhances their sensitivity to electrolytes,
which can strongly limit the field of their biological appli-
cations. The use of nonionic amphipathic polymers then
appears preferable, as a way to avoid this drawback. This is
the main reason, in the following report, our choice has
consisted of replacing the negatively charged compound
DCP and a part of cholesterol molecules with PEG-grafted
cholesterol while conserving the equimolarity between
C16G2 and cholesteryl anchors. PEGylated cholesterol
seemed quite appropriate, all the more so as recent investi-
gations have shown that PEG cholesteryl ether (Uchegbu et
al., 1992; Uchegbu and Florence, 1995) or sebacate diester
(Chopineau et al., 1994) can be introduced at low levels in
these vesicles while preserving the lamellar arrangement of
the lipids assemblies. Moreover, the ability of PEG cho-
lesteryl ether to prolong circulation half-lives of liposomes
in vivo has also been stated (Allen et al., 1991; Ishiwata et
al., 1995; Vertut-Doı¨ et al., 1996), showing even better
efficiency than PEG-distearoylphosphatidylethanolamine
(PEG-DSPE), which is usually employed (Vertut-Doı¨ et al.,
1996; Schneider et al., 1996). It could be anticipated that
choosing one constituent of NSVs as the PEG hydrophobic
anchor, i.e., cholesterol, was specially suitable for minimiz-
ing the structural perturbations of the host bilayer upon
incorporation of PEG additive. The structural characteristics
of the resulting colloidal dispersions were examined as a
function of both polymer content and length. The evolution
of the aggregate morphology with the polyoxyethylene
chain grafting density was discussed in terms of phase
behavior of the lipid-polymer mixtures. The implication of
the PEG chain conformation in this behavior was examined
on the basis of a theoretical approach.
MATERIALS AND METHODS
Chemicals
Cholesterol and n-octyl--D-glucopyranoside (octyl glucoside, OG, purity
98%, M  292.4) were purchased from Sigma. Dicetyl phosphate (DCP,
purity  97%, M  546.9) and diglycerol hexadecyl ether (linear isomer
C16H33-(O-CH2-CH(OH)-CH2)2-OH, C16G2, purity  99% (Lesieur et al.,
1990), M  390) were supplied by L’Ore´al (Chevilly-Larue, France).
Cholesteryl chloroformate (CholCl, purity 99%, M  449.12) and tet-
rabutylammonium chloride (Bu4NCl, purity 97%, M  277.92) were
purchased from Fluka. Monomethoxypoly(ethylene glycol) (M-PEG) with
molecular weights of 1000 and 2000 (M-PEG1000 and M-PEG2000,
respectively), characterized by a very low polydispersity index close to
1.05 according to the supplier, were from Shearwater Polymers Europe;
their monomethyl functionality was confirmed by 1H NMR. The buffer
consisted of a 10 mM HEPES (Sigma) and 145 mM NaCl aqueous solution
adjusted to pH 7.4 with 1 M NaOH.
Synthesis and purification of
monomethoxypoly(ethylene glycol)
cholesteryl carbonate
Monomethoxypoly(ethylene glycol) cholesteryl carbonate (M-PEG-Chol)
has been synthesized in one step by the reaction of M-PEG on CholCl,
using moderate phase transfer catalysis conditions previously described for
the nucleophilic substitution of poly(vinyl chloroformate) by phenol
(Boivin et al., 1983, 1985, 1988). In a typical experiment, 2.5 mmol of
polymer dissolved in 10 ml CH2Cl2 was added dropwise to a magnetically
stirred mixture containing 2.5 mmol of CholCl in 20 ml CH2Cl2, 0.125
mmol of Bu4NCl (5 mol% of each reagent), and 3.75 mmol of NaOH in
water (33 weight %) as HCl scavenger. The reaction scheme was as
follows:
The reaction was carried out at room temperature, under nitrogen and
continuous stirring. The formation of the M-PEG carbonate derivative was
followed by thin-layer chromatography (plates RP-18, Merck; EtOH-
CH2Cl2, 88:12, v/v) and infrared spectroscopy performed in CH2Cl2 with
a Perkin-Elmer 782 apparatus. Substitution of chlorine in CholCl by
M-PEG leads to the shift of the carbonyl absorption band from 1775 cm1
to 1745 cm1 (Fig. 1, spectra b–d), resulting from the change in the
electronegativity of the neighboring -atom of the carbonyl group (Boivin
et al., 1983). The reaction was stopped after 7 days. The mixture was
filtered to remove NaCl, and CH2Cl2 was evaporated under reduced
pressure. The solid residue was suspended in 3 ml of ethyl acetate and
deposited on the top of a 3  40 cm silica gel column. Unreacted CholCl
and cholesterol formed by side hydrolysis of a small proportion of chlo-
roformate molecules were first separated, using ethyl acetate as eluant.
M-PEG-Chol and the remaining M-PEG were then recovered with EtOH-
CH2Cl2, 9:91. The separation of M-PEG-Chol fromM-PEG was performed
by reverse-phase high-performance liquid chromatography (HPLC) on a
10.5 mm  25 cm RSIL-C18HL preparative column (porosity, 10 m;
Touzart et Matignon) with methanol (HPLC grade; Prolabo) as the mobile
phase (flow rate, 1 ml/min). The chromatograms obtained were similar to
the one in Fig. 2. Methanol was rotavapped from the fraction containing
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M-PEG-Chol, which was then dried overnight under high vacuum and then
stored at 20°C before use. Reaction yields after purification steps were
found to be close to 30%.
The purity of M-PEG-Chol was checked by reverse-phase HPLC and
infrared absorption analysis, particularly in the 1900–1500 cm1 wave-
number range (Fig. 1, spectrum e). Regarding this, the band at 1615 cm 1
noticed for the initial M-PEG (Fig. 1, spectrum a), very likely due to
unsaturated contaminants (Nadeau, 1967), was still observable for the
nonpurified intermediate reaction mixtures (Fig. 1, spectra c, d), but had
totally vanished after the purification procedure; only the carbonyl band at
1745 cm1 characteristic of the carbonate group was recovered (Fig. 1,
spectrum e). The purity of the polymer derivative was confirmed by 1H
NMR performed in CDCl3 at 20°C with a 400 MHz Bru¨ker instrument. The
principal proton chemical shifts were (in ppm) (see reaction scheme for
assignments): 5.35 (m, cholesteryl C(6)-H, 1H), 4.43 (m, cholesteryl
C(3)-H, 1H), 4.23 (t, PEG CH()2, 2H), 3.78–3.42 (PEG CH()2, (4n-
4)H), 3.34 (s, PEG O-CH3, 3H), 2.35 (m, cholesteryl C(4)-H2, 2H),
1.99–0.64 (other cholesteryl H, 41H). Ratios of experimental integrations
of signals located at 4.23 ppm (related to PEG moiety) and at either 4.43
ppm (related to cholesteryl moiety) or 3.34 ppm (methoxy group of PEG)
ensured that each PEG chain is terminated at one end by one cholesteryl
group and at the second end by one methoxy group.
Mixed aggregates preparation
Nonionic surfactant vesicles based on C16G2, cholesterol, and DCP (48.0/
48.4/3.6 mol%) were prepared by ultrasonic irradiation according to a
procedure already detailed (Lesieur et al., 1990). M-PEG-coated particles
were formed similarly. Chloroformic solutions of C16G2, cholesterol, and
M-PEG-Chol (50/50-x/xmol%, x 2, 5, 10, 20, 30) were evaporated under
a gentle stream of nitrogen to obtain thin mixed lipid films (total lipid 
15 mol). Residual organic solvent was eliminated by lyophilization. The
films were hydrated with 3 ml buffer and vortexed. The lipid dispersions
were maintained at 60°C for 4 h in hermetically closed flasks and alter-
nately vortexed until complete homogenization. The milky suspensions
were then ultrasonicated at 20°C for 6  2 min at power level 1.5, using
a Vibracell Sonifier titanium probe (Sonics and Materials Corporation).
The samples were finally centrifuged for 10 min at 10,000 rev./min to
remove titanium particles of the ultrasonifier probe and filtered through a
0.22-m Millex filter. Preparations were stored at room temperature.
Surface tension measurement
Surface tensions were measured with a Sanborn tensiometer. All experi-
ments were performed at 23°C under saturated vapor pressure. The glass-
ware was cleaned in a freshly prepared sulfochromic solution, abundantly
rinsed with triply distilled water, and dried before use. Surfactant solutions
were prepared in the usual buffer previously purified by foaming. The
surface of the surfactant solution was cleaned by aspiration just before each
measurement. The surface tension was then monitored continuously as a
function of time, using the Wilhelmy plate method. The recordings were
stopped after the surface tension had reached a constant value.
Quasielastic light scattering
The quasielastic light scattering (QELS) measurements were performed
with a nanosizer apparatus (Coulter Electronics). The scattered light was
detected at 90°, and the samples were diluted with buffer to a 1 mM total
lipid concentration just before measurement. In such high dilution condi-
tions, the Stokes law can be applied, and the particle hydrodynamic radius
(RH) is given by the Stokes-Einstein equation (Candau, 1986):
D kBT/6RH
where D is the free-particle diffusion coefficient, kB is Boltzmann’s con-
stant, T is the absolute temperature, and  is the viscosity of the continuous
phase. To take into account the sample size polydispersity, a unimodal
analysis assuming a log-Gaussian distribution was used. For all samples,
the standard deviation of three independent measurements was typically
found to be lower than 5% of the RH value.
High performance gel exclusion chromatography
Aggregate size distributions were determined using a HPLC apparatus
already described (Ollivon et al., 1986; Lesieur et al., 1993). The 0.75 
FIGURE 1 Infrared spectra of M-PEG (a) and CholCl (b) in CH2Cl2,
organic phase formed during M-PEG2000-Chol synthesis at 3 days (c) and
7 days (d), 20 mM purified M-PEG2000-Chol in CH2Cl2 (e). The substi-
tution of chlorine atoms in CholCl by M-PEG moieties is depicted by the
shift of the carbonyl band from 1775 cm1 to 1745 cm1.
FIGURE 2 Preparative HPLC of M-PEG2000-Chol derivative in re-
verse-phase conditions on C18 alkylsilica (eluant, methanol; flow rate, 1
ml/min; refractive index detection): 1, solvent front; 2, remaining M-PEG;
3, M-PEG-Chol derivative.
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30 cm TSK-G6000 PW column was supplied by Toyo Soda (Tokyo,
Japan). The eluant (flow rate 1 ml/min) was the buffer used for vesicle
preparations. Before each analysis series, the column was saturated with
lipids. Sample loadings were 50 l. Material detection was performed by
on-line turbidity measurements with a Hitachi multichannel detector
(model L-3000) in the 200–360 nm range. Elution volumes Ve were taken
at the intercept of the half-height tangents of the elution peaks. Particle
hydrodynamic diameters were deduced from the column parameter:
kd Ve	 Vo/Vt	 Vo (1)
where Vo is the effective void volume (3.98 ml from elution of 1 m
phospholipidic vesicles), and Vt is the total volume (11.01 ml from elution
of sodium azide) of the column, and according to the equation of the gel
selectivity curve (Lesieur et al., 1993),
logMD 3.03	 4.43kd
 9.63kd2	 8.85kd3 (2)
Three independent sample injections provide mean diameter determina-
tions with standard deviations from 5% to 10%, depending on the size
range of the particles (Lesieur et al., 1993).
Cryogenic transmission electron microscopy
The technique used for the cryogenic transmission electron microscopy
(cryo-TEM) examination has been described in detail elsewhere (Bellare et
al., 1988; Dubochet et al., 1988), but consisted, in short, of the following.
Thin, 10–500-nm sample films were prepared under controlled tempera-
ture (25°C) and humidity conditions within a custom-built environmental
chamber. The films were thereafter vitrified by quick freezing in liquid
ethane and transferred to a Zeiss EM 902 transmission electron microscope
for examination. To prevent sample perturbation and the formation of ice
crystals, the specimens were kept cool, below 108 K, during both the
transfer and viewing procedures. All observations were made in zero-loss
bright-field mode and at an accelerating voltage of 80 kV. To ensure
reproducibility, the selection of micrographs presented in the article was
chosen from a large number of negatives. For the evaluation of the
cryo-TEM micrographs, it is important to realize that the two-dimensional
projection of a closed liposome will appear as a circular object with
enhanced contrast around the rim. This is due to the fact that the projected
thickness of the bilayer shell is maximum at the edges. On the other hand,
the projection of a flat bilayer disk will appear even in contrast right up to
the edge.
Small-angle x-ray scattering
The preliminary x-ray scattering experiments were carried out on the D22
line of the DCI Synchrotron source at LURE (Orsay, France). The record-
ings were performed by using a radiation of wavelength 1.38 Å and a 1024
channel Xe-ethane-filled linear detector. The patterns were normalized
with respect to Synchrotron beam decay, acquisition time, and punctually
to sample transmission. The samples were prepared in a manner similar to
that of the highly diluted mixtures, as described above, however without
ultrasonic irradiation. Phase separation was performed in a narrow tube 5
mm in diameter, closed under argon. Thin glass capillaries (GLAS, Mu¨ller,
Berlin) were used as sample cells for small-angle x-ray scattering (SAXS)
measurements.
RESULTS
Surface properties of M-PEG-Chol compounds
Lowering of the surface tension of buffer by the addition of
the cholesterol derivatives was observed whatever the chain
length of the poly(ethylene glycol) moiety, showing that
they are surface-active agents. The equilibrium surface ten-
sion versus surfactant concentration plots are reported in
Fig. 3. The critical micelle concentrations (cmc) were de-
termined from the breaks in the curves, which yielded 0.8
M for M-PEG1000-Chol and 0.4 M for M-PEG2000-
Chol. Cryo-TEM analysis of polymer solutions at concen-
trations above the cmc confirms the existence of micelles.
Whatever the molecular weight of the cholesterol deriva-
tive, they present a globular structure very close to that
shown in Fig. 4 for M-PEG2000-Chol. The micellar diam-
eters revealed for both compounds are close to the limit of
the size resolution (1 nm) and contrast with the hydrody-
namic diameters deduced from QELS measurements by
assimilating the micelles to spheres (13 	 3 nm and 12 	
2 nm from M-PEG1000-Chol and M-PEG2000-Chol, re-
spectively). This difference may be partly explained by the
presence of a water layer at the micelle surface, contributing
to the overestimation of their size by QELS. However, the
10-nm shift between the two diameter determinations
strongly suggests that the electron density of the PEG chains
is matched by buffer, so that they cannot be visualized by
electron microscopy.
Cryo-TEM
Structural features of the C16G2/cholesterol/M-PEG-Chol
mixed aggregates were revealed by cryo-TEM. All of the
specimens were prepared within 2 weeks after ultrasonic
irradiation. Samples containing M-PEG1000-Chol at molar
ratios ranging from 2% to 30% were examined (Fig. 5). The
incorporation of low polymer amounts (5 mol%) gives
rise to unilamellar and rather polydisperse vesicles, as
shown in Fig. 5, a and b. Spherical vesicles with diameters
mainly ranging from 20 nm to 200 nm coexist with elon-
gated ones, comparable to cylinders and varying from 100
nm to more than 500 nm in length and from 40 nm to 80 nm
in width. Increasing polymer content up to 10 mol% leads to
a narrower size distribution. The elongated structures have
almost disappeared, and vesicles, predominantly spheroidal,
with diameters in the 35–170-nm range are formed (Fig. 5
c). At this stage, the particle membrane exhibits an irregular
FIGURE 3 Surface tension-log concentration curves of M-PEG1000-
Chol (‚) and M-PEG2000-Chol (Œ) in buffer.
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surface, as if the vesicles were delimited by a rippling
bilayer. The sample containing 20% M-PEG1000-Chol
shows two coexisting aggregate populations (Fig. 5 d). On
one hand, vesicles are still present. They are mainly spher-
ical and monodisperse, with 80–100-nm diameters. Some of
the vesicles appear to have openings. On the other hand,
disk-shaped aggregates, very likely bilayer fragments, can
be observed either edge on, face on, or at all orientations in
between. The disks are nearly 4 nm thick and vary from 15
nm to 130 nm in diameter. Finally, at 30 mol%
FIGURE 4 Cryo-TEM picture of a
2 mMM-PEG2000-Chol micellar so-
lution in buffer. Bar, 100 nm.
FIGURE 5 Cryo-TEM pictures of C16G2/cholesterol/M-PEG1000-Chol (50/50-x/x mol%) mixed aggregates. The total lipid concentration is 2 mM. (a)
x  2 mol%: a majority of small unilamellar vesicles can be seen with either spherical or elongated shapes. Some long cylindrical structures (L) are also
observed; the polymer film (P) is included in the picture for clarity. (b) x  5 mol%: structures similar to the preceding ones. (c) x  10 mol%: spheroidal
unilamellar vesicles showing an irregular bilayer surface. (d) x  20 mol%: unilamellar vesicles, almost all of them spherical, coexist with discoid
aggregates seen either edge on (E) or face on (F) or at all orientations in between. Some of the vesicles appear open (O). (e) x  30 mol%: the mixed
aggregates are viewed as bilayered disks. (f) Vesicles belonging to samples containing x  2 mol% (left side of the picture) and x  10 mol% (right side
of the picture) M-PEG1000-Chol. The enrichment in polymer clearly generates rough vesicles. Bar, 100 nm.
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M-PEG1000-Chol, no more vesicles, but only disk-shaped
aggregates are observed (Fig. 5 e). Their diameter is re-
duced compared to the preceding sample and does not
exceed 30 nm.
Samples containing M-PEG2000-Chol present a very
similar behavior (Fig. 6). Nevertheless, the characteristic
steps of the aggregate evolution correspond to polymer
ratios systematically lower than those noticed for the
M-PEG1000-Chol-based system. At 2 mol% M-PEG2000-
Chol, only vesicles, mainly unilamellar, are observed (Fig.
6 a). Spherical structures (diameters from 25 nm to 100 nm)
coexist with elongated or peanut-shaped arrangements
(width 
80 nm, length several hundred nanometers). With
an increasing polymer level of 2–5 mol% (Fig. 6 b), the
particle shape polydispersity decreases significantly, to the
detriment of elongated structures, and the vesicles begin to
present an undulating surface. Incorporation of 10 mol%
M-PEG2000-Chol induces the appearance of disk-shaped
aggregates in addition to the remaining undamaged vesicles
(Fig. 6 c). The pictures corresponding to higher polymer
ratios reveal the formation of only disk-like structures, with
diameters ranging from several to a hundred nanometers
(Fig. 6 d).
QELS analysis
The apparent diffusion coefficients D of the C16G2/choles-
terol/M-PEG-Chol (50/50-x/x mol%) mixed aggregates
were measured at a 90° scattering angle. For each sample,
nearly constant values were recorded over a 2-week period
(Fig. 7), indicating appreciable size stability of the aggre-
gates whatever the polymer molar ratio and chain length.
Table 1 shows the evolution with time of the mean hydro-
dynamic diameter (2RH) for the aggregates containing either
10 mol% M-PEG1000-Chol or 5 mol% M-PEG2000-Chol,
which are indeed seen to be mostly spherical in the cryo-
TEM pictures. The very slight fluctuations in the size pa-
rameters, including 2RH and standard deviation values, il-
lustrate the aggregate stability. This last is very comparable
to that observed for nonionic surfactant vesicles (NSVs)
FIGURE 6 Cryo-TEM pictures of C16G2/cholesterol/M-PEG2000-Chol (50/50-x/x mol%) mixed aggregates. The total lipid concentration is 2 mM. (a)
x  2 mol%: spherical and elongated vesicles, mostly unilamellar, coexist. Arrows denote some frost deposited on the sample after vitrification. (b) x 
5 mol%: single-walled spheroidal vesicles with apparently wavy external surface can be seen. (c) x  10 mol%: mostly spherical unilamellar vesicles are
revealed beside sparse peanut-shaped ones, in coexistence with disk-shaped aggregates. (d) x  20 mol%: only discoid structures are observed edge on (E)
or face on (F). Bar, 100 nm.
FIGURE 7 Evolution of the apparent diffusion coefficient of the (A)
C16G2/cholesterol/M-PEG1000-Chol (50/50-x/x mol%) and (B) C16G2/
cholesterol/M-PEG2000-Chol (50/50-x/x mol%) mixed aggregates as a
function of polymer ratio, after storage periods of 1 (), 3 (), 8 (E), and
15 () days. The inset shows the variation in the apparent diffusion
coefficient with time for NSV (C16G2/cholesterol/DCP: 48.0/48.4/3.6
mol%). The QELS analyses were performed at a 90° scattering angle.
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composed of C16G2 and cholesterol and stabilized by a low
proportion of the negatively charged compound DCP (Fig.
7, inset, and Seras et al., 1992).
The comparison of the QELS diameters shown in Table 1
with sizes reported by cryo-TEM (Figs. 5 c and 6 b) de-
serves attention. A tendency of QELS to overestimate the
effective geometrical diameter of the particles can be no-
ticed, especially in the case of the M-PEG2000-Chol aggre-
gates. Given the nonnegligible standard deviations mea-
sured, this is due partly to the weighting toward the larger
particles in a polydisperse system, inherent in QELS mea-
surements, as has been both experimentally and theoreti-
cally demonstrated (Wong and Thompson, 1982). The pos-
sibility is also not excluded that, because of the presence of
hydrophilic PEG chains at their surface, the vesicles drag
water molecules in their Brownian motion, so that their
hydrodynamic radius appears larger than the geometric one
(Corti, 1985). In the latter hypothesis and according to our
results, the hydration effect would be more important for
PEG chains with a molecular weight of 2000.
HPLC-GEC analysis
Sizing of M-PEG-coated aggregates was also performed by
high-performance gel exclusion chromatography (HPLC-
GEC) coupled with turbidity on-line detection. The analysis
was carried out 1 week after sample preparation. Fig. 8,a
and b, shows the chromatograms obtained as a function of
polymer chain length and molar ratio. NSVs were also
analyzed as a reference. Most of the gel exclusion patterns
present similar shapes consisting of nearly symmetrical
peaks, attributable to unimodal size distributions. Some of
the elution profiles also display a very slight shoulder (Ve
10.81 ml) close to the total volume of the column and thus
corresponding to very small particles. This shoulder tends to
be amplified by high M-PEG-Chol contents. For low poly-
mer ratios as well as for NSVs, the maxima of the chro-
matograms, i.e., the hydrodynamic sizes, are varying in a
very narrow interval (Ve, from 8.42 to 8.55 ml). At inter-
mediate polymer levels corresponding to the vesicle-disk
coexistence domain revealed by cryo-TEM, the GEC pro-
files only account for unimodal size distributions due to size
closeness between both types of aggregates. In return, ag-
gregates containing 30 mol% of M-PEG1000-Chol or from
20 mol% to 30 mol% of M-PEG2000-Chol display signif-
icant shifts of their GEC peaks toward the elution region of
smaller particles (Ve, from 9.05 to 9.67 ml), compared to
vesicle elution range. This progressive decrease in size with
increasing polymer molecular weight or molar ratio de-
picted by HPLC-GEC agrees with the size decrease ob-
served in the disk domain by cryo-TEM.
Mean hydrodynamic diameters were calculated from the
TSK G6000 PW selectivity curve already established (Le-
sieur et al., 1993), and are reported in the insets of Fig. 7, a
and b. The results are in accord with the size distributions
observed by cryo-TEM, when limited to spheroid or discoid
TABLE 1 Mean hydrodynamic diameters (2RH) over a 15-day





x  10 mol%*
M-PEG2000-Chol









99 36 103 36
3 100 38 102 35
8 97 36 100 33
15 104 33 112 38
*x is the polymer molar ratio of the mixed aggregates composed of
C16G2/cholesterol/M-PEG-Chol (50/50-x/x mol%)
#The standard deviation corresponds to a unimodal analysis assuming a
log-Gaussian particle size distribution.
FIGURE 8 HPLC gel exclusion profiles of NSV (C16G2/cholesterol/
DCP: 48.0/48.4/3.6 mol%) and C16G2/cholesterol/M-PEG-Chol (50/50-x/x
mol%) mixed aggregates 1 week after ultrasonic irradiation, relative to
M-PEG1000-Chol (a) and M-PEG2000-Chol (b). Percentages refer to
M-PEG-Chol molar ratios x and Ve to the elution volume. HPLC patterns
were performed with 50-l sample loading and a eluant flow rate of 1
ml/min. The effective void volume of the column was 3.98 ml (from
elution of 1 m phospholipidic vesicles), and the total volume was 11.01
ml (from elution of sodium azide). The insets show the evolution versus
M-PEG-Chol content of the mean hydrodynamic diameter, deduced from
the kd value at the maximum of the chromatograms and Eq. 2 (see
Materials and Methods).
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particles. In return, the GEC MD found at M-PEG1000-
Chol and M-PEG2000-Chol ratios lower than 10 mol% and
5 mol%, respectively, and the unimodal elution profiles do
not reveal the length of the large rod-like aggregates that
should be eluted at the void volume of the column. This
suggests that, under the HPLC conditions that impose a flow
constraint, the cylindrical vesicles may be allowed to pen-
etrate lengthwise the pores of the gel, so that the retention
times only report the cylinder widths (Seras et al., 1996).
Indeed, HPLC-GEC indicates MD values in the 60–70-nm
range, which coincides with the range of cylinder widths
seen in micrographs.
DISCUSSION
Characteristics of the M-PEG-Chol conjugates
The formation of a stable lamellar phase by mixing lipids
and a PEG-lipid conjugate depends not only on the nature of
the hydrophobic residue of the conjugate, but also on its
hydrophilic chain length (Torchilin, 1996; Allen, 1994a;
Bedu-Addo and Huang, 1995; Hristova et al., 1995; Ken-
worthy et al., 1995b). The adjustment of the latter results
from the compromise between optimizing the steric barrier
by using rather long PEG chains and minimizing mixed
micelle formation. The hydrophilic-lipophilic balance
should also be chosen to lower the water solubility of the
PEGylated surfactant. That is, values of cmc that are too
high strongly limit incorporation levels of the surfactant in
lipid bilayers and dramatically favor its removal from the
vesicles upon dilution. According to studies on PEGylated
phospholipids, the best miscibilities with guest phospholip-
idic lamellar phases were typically obtained for PEG mo-
lecular weights of 1000–5000 (Bedu-Addo and Huang,
1995; Bedu-Addo et al., 1996a,b). The same result was
recently described in the case of PEG cholesteryl ether
(Ishiwata et al., 1995; Vertut-Doı¨ et al., 1996). In the
biological environment, the protection against phagocytosis
was improved with increasing PEG chain length up to a
molecular weight of 2000, whereas beyond this value, blood
circulation times are not significantly changed (Allen et al.,
1991). These reports incited us to restrict our study to the
examination of the two PEG molecular weights, a priori
delimiting the most efficient chain lengths, i.e., 1000 and
2000, respectively. The corresponding M-PEG cholesteryl
carbonates advantageously display very low solubilities in
buffer with cmc plainly below 1 M, against 6 M reported
in saline medium conditions for PEG1900-DSPE (Uster et
al., 1996) and 2–4 M for PEG2200 cholesteryl ether
(Ishiwata et al., 1995) in water. However, in the latter case,
the difference may arise from the presence of 145 mM NaCl
in our buffer, which may reduce the surfactant solubility, as
already suggested in the case of phospholipidic derivatives
(Lasic, 1994). Unlike what is generally observed for alkyl
ethylene oxide (EO) surfactants containing less than 10 EO
units (Becher, 1966), M-PEG-Chol exhibit decreasing cmc
with increasing PEG chain length, even when cmc is ex-
pressed in units of weight per volume (1.13 mg/liter for
M-PEG1000-Chol and 0.72 mg/l for M-PEG2000-Chol).
This has also been observed in the case of the cholesteryl
ether derivatives with PEG molecular weights ranging from
2200 to 8800 (Ishiwata et al., 1995). Such a behavior seems
more plausibly inherent in the cholesterol hydrophobic moi-
ety rather than in water solubility differences of PEG chains,
especially in the 20–45-EO unit range.
Aggregation behavior of highly hydrated C16G2/
cholesterol/M-PEG-Chol mixtures
The images revealed in this study outline three main struc-
tural domains as a function of polymer level. Below 10
mol% M-PEG1000-Chol or 5 mol% M-PEG2000-Chol,
only vesicles are formed: the absence of micelles on the
cryo-TEM pictures and GEC profiles shows the highly
efficient incorporation of PEGylated cholesterol into the
C16G2/cholesterol assemblies, while preserving closed bi-
layered structures, stable over 2 weeks at least. Polymer
saturation ratios of 20 mol% M-PEG1000-Chol or 10 mol%
M-PEG2000-Chol yield two coexisting particle popula-
tions: vesicles and disk-shaped bilayer fragments. Finally,
higher M-PEG-Chol amounts lead to the disappearance of
the vesicles; only disks are obtained.
The vesicular domain shows sensitivity of both geometry
and size of the particles to the M-PEG-Chol membrane
composition. Very low polymer levels produce heteroge-
neous vesicle populations composed of coexisting spherical
and cylindrical units. An increase in M-PEG-Chol content
reduces the shape polydispersity by favoring the formation
of spherical vesicles. The best homogenization of the pop-
ulations is reached at the saturation of the lipids bilayers in
polymer, i.e., when the disks begin to form. The ability of
PEGylated compounds to transform deformed vesicles into
nearly calibrated and spherical ones has also been depicted
for systems based on PEGylated phosphatidylethanolamine
(PEG-PE) and phospholipids associated (Edwards et al.,
1996) or not (Lasic et al., 1991) with cholesterol. Such
morphological evolution is comparable to that already ob-
served when the solubilizing surfactant octyl glucoside
(OG) was added to NSVs (Seras et al., 1996) or to egg
phosphatidylcholine vesicles (Vinson et al., 1989). Shape
and size transformations of the mixed vesicles were inter-
preted as a function of the distribution of the surfactant
molecules among the lipidic assemblies. For the NSV-OG
system, time-resolved fluorescence experiments demon-
strated that the appearance of elongated structures at low
surfactant compositions corresponds to the heterogeneous
location of OG within the vesicle membrane, whereas
spherical particles observed at high surfactant content
present uniform molecular distribution (Seras et al., 1992,
1994, 1996). It can be expected that the bilayer curvature of
the C16G2/cholesterol/M-PEG-Chol mixed vesicles is simi-
larly governed by the distribution of the polymer derivative
in the lipidic matrix.
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In the vesicle-disk coexistence domain, open vesicles are
seen in the micrographs. This observation is not new, be-
cause open vesicles have been visualized by cryo-TEM in a
number of other lipid-surfactant systems (Walter, 1992).
The images presented in this study show properly vitrified
films, giving evidence that the quenching of the samples by
freezing in CEVS conditions was almost instantaneous
(Dubochet et al., 1988), which should not allow comparably
slow major rearrangements of the lipid molecules to pro-
duce an open vesicle. It is more probable that these rear-
rangements occur in the samples before specimen prepara-
tion and are only connected with the polymer enrichment,
because no open vesicles are revealed at subsaturation lev-
els of M-PEG-Chol. Nevertheless, even if the opening of the
vesicles was, in a certain extent, due to the sample filming
procedure, this would be evidence of vesicle brittleness at
high polymer incorporation. Accordingly, it has been dem-
onstrated that grafting polymers to lipid bilayers affects the
area compressibility modulus of the bilayers and hence
reduces their mechanical stability (Hristova and Needham,
1994).
The third domain described by the cryo-TEM pictures is
only constituted of disks and appears to be optically isotro-
pic. The aggregate thickness, estimated to be 4 nm, is equal
to the hydrophobic thickness of a dehydrated C16G2/choles-
terol (50/50 mol%) bilayer (Vanlerberghe et al., 1978). By
considering that the PEG chains are not revealed by this
technique (see the Results), it implies that the disk core is
composed of flat sheets of uninterdigitated lipid bilayer.
Similarly, it has been already shown by x-ray diffraction
that the incorporation of high levels of PEG2000-DSPE into
distearoylphosphatidylcholine bilayers does not induce lipid
interdigitation (Kenworthy et al., 1995b). The formation of
bilayered disks has also been observed for phospholipid/
cholesterol/PEG-PE mixtures: the perfectly planar and cir-
cular forms, as well as the preservation of disk shape, at
high PEGylated lipid levels instead of transformation into
thread-like micelles, have been shown to be specific for
cholesterol-containing aggregates (Edwards et al., 1996).
Despite the nonnegligible polydispersity of the disk popu-
lations, both cryo-TEM and HPLC-GEC clearly show the
decrease in disk diameter with increasing polymer propor-
tion. This suggests the preferential location of the polymer
at the disk circumference: the disk core would be based on
a C16G2/cholesterol/M-PEG-Chol mixed bilayer saturated
in polymer, whereas the exceeding M-PEG-Chol molecules
would constitute the edges of the disks. This model has
already been proposed for bile salt-phospholipid mixtures
(Mazer et al., 1990).
Conformation of the PEG chains at the
vesicle surface
The structural state of the polyoxyethylenic chains coating
the vesicles can be predicted by the scaling laws describing
the conformation of flexible polymer chains grafted to a
planar surface and immersed in a good solvent (Alexander,
1977; de Gennes, 1980). Indeed, PEG is highly soluble in
the aqueous buffer used in this study. In addition, the vesicle
shell can be reasonably approximated to a planar surface,
assuming the particle diameters to be very large compared
to the maximum PEG chain extension, expected to be below
6 nm from both experimental data (Kuhl et al., 1994;
Kenworthy et al., 1995b) and theoretical calculation (see
Table 2). By comparing the average distance between graft-
ing sites, d, to the Flory radius, RF  N3/5a, given for a
coiled chain in a good solvent with N monomer units of
length a, two principal regimes have been defined (de
Gennes, 1980): for d  RF, the polymer develops as sepa-
rate coils or mushrooms, whereas for d  RF, the chains
overlap and adopt a stretched state or brush regime. In this
second case, the thickness of the grafted polymer layer is
L  Na5/3/d2/3. The d values as well as the nature of the
PEG chain conformation and their extension L in the brush
regime are reported in Table 2. It is worth noting that our
calculated L values for the extended length of M-PEG2000
chains agree well with values ranging from 35 Å to 50–65
Å, experimentally determined from other lipidic systems, by
increasing the PEG2000-lipid molar ratio from 5 mol% to
10 mol% (Janzen et al., 1996; Hristova et al., 1995; Kuhl et
al., 1994; Kenworthy et al., 1995a,b; Shimada et al., 1995;
Woodle et al., 1992). This agreement reasonably validates
the theoretical calculations of the PEG coating thicknesses
in our study.
The conformation transition from mushrooms to brushes,
at a molar ratio x close to 7.5 mol% M-PEG1000-Chol or
3.5 mol% M-PEG2000-Chol, interestingly coincides with
the disappearance of the elongated vesicle shapes accom-
panied by size decrease and bilayer curvature homogeniza-
tion. It is conceivable that the important steric repulsions
TABLE 2 Theoretical distance between grafting sites, d, and
brush thickness, L, of the PEG chains, as a function of their
length and grafting density at the vesicle surface.
x (mol%)* d (Å)#
M-PEG1000-Chol M-PEG2000-Chol
Conformation§ L (Å)¶ Conformation§ L (Å)¶
2 44 M — M —
5 28 M — B 39
10 18 B 27 B 53
20 14 B 32 — —
*Vesicles composed of C16G2/cholesterol/M-PEG-Chol (50/50-x/x mol%)
#The distance between grafting sites d was calculated from the polymer
molar fraction x and the average surface area given for a C16G2/cholesterol
(50/50 mol%) bilayer (Vanlerberghe et al., 1978), according to the expres-
sion d  (39/x)1/2 (Kenworthy et al., 1995).
§The conformation state of the PEG chains at the vesicle surface was
derived from the comparison of the distance d between grafting sites and
the Flory radius, RF N3/5a, of the M-PEG polymers. RF values calculated
for M-PEG1000 (N  23) and M-PEG2000 (N  45) moieties are 23 Å
and 34 Å, respectively, taking a  3.5 Å (Kuhl et al., 1994; Kenworthy et
al., 1995a, b). N, OE unit number; a, OE unit length. Mushroom (M) or
brush (B) regimes correspond to d  RF or d  RF.
¶The extended length of the PEG chains in the brush regime is given by
L  Na5/3/d2/3 (de Gennes, 1980).
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between the M-PEG-Chol headgroups caused by their
denser distribution impose a random distribution of the
polymer to minimize chain overlapping, which is in favor of
a spherical shape. The denser distribution of the brush may
generate packing irregularities of the lipid molecules, as
suggested by the rough vesicle surface seen in the micro-
graphs (Figs. 5 c, f and 6 c). On the other hand, the QELS
measurements demonstrate the size stability with time of the
M-PEG-Chol-coated vesicles, proving the efficiency of M-
PEG-Chol in creating a steric barrier at the particle surface,
preventing them from self-aggregation and fusion. Regard-
ing biological applications, the achievement of stable vesi-
cles coated by PEG chains in the brush conformational state
is encouraging; previous investigations have actually dem-
onstrated that liposome stealthiness is improved by increas-
ing both PEG chain extension and density (Lasic, 1996;
Needham et al., 1992).
However, there is a limit to the density of the PEG chains
in the brush regime: a too high polymer content leads to
vesicle disruption and disk formation. The impossibility, at
this stage, of bending the bilayer may arise from an increase
in the lateral steric repulsion between neighboring chains.
At the M-PEG-Chol saturation levels (between 10 mol%
and 20 mol% M-PEG1000-Chol or 5 mol% and 10 mol%
M-PEG2000-Chol), the theoretical model forecasts PEG
thicknesses close to 30 Å or 45 Å, against 23 Å and 34 Å in
the mushroom regime, depending on the PEG molecular
weight (Table 2). Given that the volume occupied by one
hydrophilic chain remains unchanged, the stretching of the
chains necessarily leads to the modification of the geomet-
rical balance between polar headgroups and cholesterol
anchors that would be in favor of a minimum curvature. The
consequence, unsuited to drug carrier applications, is the
generation of open structures, leading to the loss of encap-
sulated material.
Vesicle to disk transition
Transition from vesicles to open structures with increasing
PEGylated lipid content and involving an intermediate do-
main in which both types of particles coexist, has been
already described for phospholipids/cholesterol/PEG-PE
systems and interpreted in terms of vesicle-to-micelle tran-
sition (Lasic et al., 1991; Edwards et al., 1996). Concur-
rently, structural investigations undertaken on these systems
or analogs have demonstrated the lamellar to micellar phase
conversion triggered by increasing the PEG derivative com-
position (Kenworthy et al., 1995b; Hristova et al., 1995;
Bedu-Addo and Huang, 1995b; Bedu-Addo et al., 1996a,b).
The solubilization of NSVs upon the addition of PEG cho-
lesteryl conjugates has been reported as well (Uchegbu et
al., 1992; Chopineau et al., 1994), and confirmed by the
corresponding partial phase diagram (Uchegbu et al., 1996).
As inspired from these reports, the rupture of the vesicles
into disk-shaped assemblies should correspond to the onset
of the lipid solubilization by the M-PEG-Chol derivatives,
insofar as these last are surface-active agents. That is, the
first dissolution step of the C16G2/cholesterol lamellar as-
semblies may be their separation into individual bilayered
particles stabilized by the surfactant molecules.
The boundary between vesicle and vesicle-disk coexist-
ence domains corresponds to a polymer saturation level of
the lipidic membrane in the 10–20 mol% M-PEG1000-Chol
and 5–10 mol% M-PEG2000-Chol ranges, respectively.
Similar critical ratios have been found when PEG-PE de-
rivatives (Lasic et al., 1991; Allen et al., 1991; Schneider et
al., 1996; Hristova et al., 1995; Edwards et al., 1996), as
well as PEG cholesteryl ether (Ishiwata et al., 1995; Vertut-
Doı¨ et al., 1996) or hemisuccinate (Schneider et al., 1996),
are incorporated into liposomes. A decrease in the saturation
level of the lipid lamellar assemblies with increasing PEG
molecular weight has also been observed (Allen et al., 1991;
Ishiwata et al., 1995; Kenworthy et al., 1995b) and attrib-
uted to the increase in bulkiness of the polymer polar
headgroup with the PEG chain lengthening (Hristova and
Needham, 1994). Complete vesicle disappearance, i.e., the
beginning of the pure disk domain, also requires more
M-PEG1000-Chol (in the 20–30 mol% range) than
M-PEG2000-Chol (in the 10–20 mol% range); the longer
the PEG chain, the better the destabilizing ability. By as-
suming the concentration of M-PEG-Chol in buffer to be
negligible, because they should not exceed 1 M with
regard to the cmc values of the pure PEGylated compounds,
the surfactant-to-lipid molar ratios in the aggregates can be
directly calculated from the total concentrations of both
constituents. Thus, at the onset of the disk domain, these
ratios can be estimated to 
0.4 or 
0.2 for M-PEG1000-
Chol or M-PEG2000-Chol, respectively. During NSV sol-
ubilization by the PEG cholesteryl ether derivative Solulan
C24 (Uchegbu et al., 1992), the formation of turbid inter-
mediate structures replacing initial vesicles has been found
at a close surfactant-to-lipid molar ratio of 0.3, These inter-
mediates, unfortunately undefined in the reported study,
may correspond to disk-like aggregates similar to those seen
in our study.
Although further work is certainly required to definitively
assimilate the disks into a micellar phase, there are already
several points in favor of this hypothesis. One argument is
the delimitation of the coexistence domain, in the M-PEG-
Chol-rich region, by only disked-shaped structures with
stable, finite, and rather small dimensions, decreasing in
size with increasing polymer level. We also observed that
less diluted preparations (85% hydration by weight), located
in the intermediate polymer concentration domain, separate
with time into a dense and turbid phase and a clear super-
natant phase. Preliminary SAXS investigations provided
information on the structural arrangement of each phase.
The small-angle SAXS pattern of the upper phase (Fig. 9 b)
is characterized by two rather broad diffraction peaks con-
trasting in intensity and centered at 0.025 Å1 and 0.070
Å1, respectively. The location of these peaks does not
reflect a lamellar organization. Moreover, this pattern ap-
pears very close in shape to that recorded from pure M-
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PEG-Chol concentrated micelles (Fig. 9 d), except for the
relative shift of the two patterns. This result supports the
possibility that the structure of the upper phase formed in
the coexistence domain is governed by the polymer-based
surfactant and probably corresponds to a micelle-like ar-
rangement. As a tentative interpretation, by attributing the
very intense peak seen at lower angles to a structure factor
contribution, this phase may be composed of the disks seen
by cryo-TEM, however, in strong interactions due to the
low hydration of the sample examined by SAXS. The whole
sample (Fig. 9 a), before macroscopic phase separation,
exhibits the superimposition of the peaks characteristic of
the upper phase, with four sharp Bragg reflections at 0.068
Å1, 0.101 Å1, 0.135 Å1, and 0.168 Å1, corresponding
to the second to the fifth orders of a single lamellar structure
of period 187 Å. Likely due to the contribution of the form
factor of the lamellae (Nallet et al., 1993), the first-order
peak that should be located at 0.033 Å1, has vanished. As
complementary information, Fig. 9 c shows a diffraction
pattern example of the lamellar phase formed before the
coexistence domain and for which the first-order reflection
is resolved.
The above observations underscore that the vesicular
structures and the disks originate from two distinct phases.
Consequently, the appearance of discoid assemblies corre-
sponds to an effective phase transition phenomenon. More-
over, unlike the vesicles, the disks seen in the water-rich
region of the phase diagram do not appear as the continu-
ation of a lamellar phase, and seem, rather, to be related to
a micellar phase.
CONCLUDING REMARKS
Among the main outlines resulting from this study, it has
been shown that new sterically stabilized vesicles can be
elaborated from the association of the synthetic nonionic
monoalkyl lipid C16G2 and cholesterol, by grafting, via a
carbonate bond, a PEG chain to a small part of the choles-
terol molecules. The physical stability of these vesicles,
over 14 days at least, added to the impermeability expected
for the equimolar C16G2/cholesterol membrane, and consti-
tutes a relevant asset with respect to potential drug delivery
applications. However, the incorporation of the PEGylated
cholesterol derivative shows two antagonistic effects, de-
pending on its proportion. Whereas low levels do contribute
to steric stabilization of the vesicles, high levels yield their
inevitable destruction. The analogy between this phase be-
havior and a vesicle-to-micelle transition mechanism rather
ranks M-PEG-Chol among the solubilizing amphiphiles.
The membrane saturation threshold at which the closed
bilayered aggregates are transformed into open disk-like
structures depends on the polymer molecular weight and
corresponds to the density of the PEG chains in their brush
conformational state. Taking into account that the most
homogeneous vesicle populations are formed at the begin-
ning of the overlapping coils regime, it happens that the
membrane composition in PEGylated lipid has to be chosen
with the greatest care, to optimize the aggregate morphol-
ogy, as well as the coating thickness responsible for the
particle steric repulsion, while avoiding the formation of
disks that would be detrimental to drug encapsulation. Such
a compromise should correspond to 
10 mol%
M-PEG1000-Chol or 
5 mol% M-PEG2000-Chol. On the
basis of this physicochemical insight, further investigations
concerning the vesicle’s encapsulation efficiency as well as
its resistance in the biological environment have been un-
dertaken (Beugin-Deroo et al., 1998).
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